CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)	12 Months Ended
	Jan. 01, 2022	Jan. 02, 2021	Dec. 28, 2019
Operating activities:
Net income	$ 66,892,000	$ 75,041,000	$ 119,447,000
Adjustments to reconcile net income to cash provided by operating activities:
Depreciation and amortization	48,550,000	50,677,000	45,017,000
Amortization of deferred financing costs and debt discount	6,136,000	8,845,000	9,318,000
Goodwill impairment		3,665,000
Impairment of intangible and long-lived assets	521,000	1,372,000	307,000
Share-based compensation expense	21,348,000	55,013,000	20,471,000
Deferred tax benefit	(15,565,000)	(1,440,000)	(9,424,000)
Allowance for doubtful accounts	(214,000)	411,000	(123,000)
Reserve for inventory obsolescence	7,657,000	16,425,000	8,710,000
Foreign currency exchange rate loss	744,000	719,000	1,235,000
Early extinguishment of debt	30,352,000
Changes in cash due to:
Receivables	4,707,000	(3,600,000)	1,331,000
Inventories	1,816,000	(25,940,000)	(9,127,000)
Prepaid expenses	1,554,000	(5,081,000)	13,619,000
Accounts payable	373,000	(4,045,000)	1,347,000
Accrued liabilities	1,272,000	(29,421,000)	(6,968,000)
Deferred revenue	(3,886,000)	(11,583,000)	6,199,000
Other long term assets and liabilities, net	(7,962,000)	1,859,000	(878,000)
Income taxes	(7,014,000)	3,023,000	(18,098,000)
Cash provided by operating activities	157,281,000	135,940,000	182,383,000
Investing activities:
Capital expenditures	(2,446,000)	(21,490,000)	(17,159,000)
Capitalized software expenditures	(35,205,000)	(28,941,000)	(30,824,000)
Cash paid for acquisitions	(12,836,000)	(10,037,000)	(4,060,000)
Other items, net	(2,266,000)	(5,123,000)	(580,000)
Cash used for investing activities	(52,753,000)	(65,591,000)	(52,623,000)
Financing activities:
Net (payments) borrowings on revolver	0	0	0
Proceeds from long term debt	1,500,000,000
Financing costs and debt discount	(37,910,000)	(475,000)
Payments on long-term debt	(1,564,000,000)	(96,250,000)	(177,000,000)
Taxes paid related to net share settlement of equity awards	(7,494,000)	(6,798,000)	(6,582,000)
Proceeds from stock options exercised	4,469,000	8,176,000	1,076,000
Cash paid for acquisitions	(6,450,000)
Other items, net	(151,000)	(192,000)	(487,000)
Cash used for financing activities	(111,536,000)	(95,539,000)	(182,993,000)
Effect of exchange rate changes on cash and cash equivalents	(5,085,000)	8,341,000	(1,005,000)
Net decrease in cash and cash equivalents	(12,093,000)	(16,849,000)	(54,238,000)
Cash and cash equivalents, beginning of period	165,887,000	182,736,000	236,974,000
Cash and cash equivalents, end of period	$ 153,794,000	$ 165,887,000	$ 182,736,000